Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tae-Min Kim

Showing results (191-200 of 613) with videos related to

Pageof 62
Sort By:
Cancer Research and Treatment|February 13, 2015
Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung CancerYun-Gyoo Lee, Eunyoung Lee, Inho Kim, et al.
The Journal of Emergency Medicine|August 30, 2008
Comparison of traditional advanced cardiac life support (ACLS) course instruction vs. a scenario-based, performance oriented team instruction (SPOTI) method for Korean paramedic studentsChristopher C Lee, Mark Im, Tae Min Kim, et al.
Cancers|November 13, 2020
Immunophenotypic Landscape and Prognosis of Diffuse Large B-Cell Lymphoma with MYC/BCL2 Double Expression: An Analysis of A Prospectively Immunoprofiled CohortBogyeong Han, Sehui Kim, Jiwon Koh, et al.
Cancer Research and Treatment|February 14, 2024
Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case SeriesHyeon Gyu Kang, Jiwon Koh, Tae Min Kim, et al.
Clinical Lung Cancer|September 30, 2018
Significance of <sup>18</sup>F-FDG PET Parameters According to Histologic Subtype in the Treatment Outcome of Stage III Non-small-cell Lung Cancer Undergoing Definitive Concurrent ChemoradiotherapyEunji Kim, Hong-Gyun Wu, Bhumsuk Keam, et al.
The Oncologist|September 27, 2018
A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part SarcomaMiso Kim, Tae Min Kim, Bhumsuk Keam, et al.
Cancer Letters|September 26, 2020
Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cellsSiyeon Park, Tae Min Kim, Sung-Yup Cho, et al.
Cancer Research and Treatment|April 29, 2016
Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program CohortMinkyu Jung, Jeeyun Lee, Tae Min Kim, et al.
Leukemia & Lymphoma|November 11, 2014
Neutrophil to lymphocyte ratio improves prognostic prediction of International Prognostic Index for patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisoneBhumsuk Keam, Hyerim Ha, Tae Min Kim, et al.
Journal of Neuro-Oncology|December 29, 2025
Documented advance care planning elements and end-of-life care patterns in malignant glioma vs. major solid tumors: a single-center retrospective studyYe Sul Jeung, Wan Taek Lee, Yejin Kim, et al.
Pageof 62

Showing results (191-200 of 613) with videos related to

Sort By:
Pageof 62
Cancer Research and Treatment|February 13, 2015
Cisplatin-Based Chemotherapy Is a Strong Risk Factor for Thromboembolic Events in Small-Cell Lung CancerYun-Gyoo Lee, Eunyoung Lee, Inho Kim, et al.
The Journal of Emergency Medicine|August 30, 2008
Comparison of traditional advanced cardiac life support (ACLS) course instruction vs. a scenario-based, performance oriented team instruction (SPOTI) method for Korean paramedic studentsChristopher C Lee, Mark Im, Tae Min Kim, et al.
Cancers|November 13, 2020
Immunophenotypic Landscape and Prognosis of Diffuse Large B-Cell Lymphoma with MYC/BCL2 Double Expression: An Analysis of A Prospectively Immunoprofiled CohortBogyeong Han, Sehui Kim, Jiwon Koh, et al.
Cancer Research and Treatment|February 14, 2024
Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case SeriesHyeon Gyu Kang, Jiwon Koh, Tae Min Kim, et al.
Clinical Lung Cancer|September 30, 2018
Significance of <sup>18</sup>F-FDG PET Parameters According to Histologic Subtype in the Treatment Outcome of Stage III Non-small-cell Lung Cancer Undergoing Definitive Concurrent ChemoradiotherapyEunji Kim, Hong-Gyun Wu, Bhumsuk Keam, et al.
The Oncologist|September 27, 2018
A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part SarcomaMiso Kim, Tae Min Kim, Bhumsuk Keam, et al.
Cancer Letters|September 26, 2020
Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cellsSiyeon Park, Tae Min Kim, Sung-Yup Cho, et al.
Cancer Research and Treatment|April 29, 2016
Ipilimumab Real-World Efficacy and Safety in Korean Melanoma Patients from the Korean Named-Patient Program CohortMinkyu Jung, Jeeyun Lee, Tae Min Kim, et al.
Leukemia & Lymphoma|November 11, 2014
Neutrophil to lymphocyte ratio improves prognostic prediction of International Prognostic Index for patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisoneBhumsuk Keam, Hyerim Ha, Tae Min Kim, et al.
Journal of Neuro-Oncology|December 29, 2025
Documented advance care planning elements and end-of-life care patterns in malignant glioma vs. major solid tumors: a single-center retrospective studyYe Sul Jeung, Wan Taek Lee, Yejin Kim, et al.
Pageof 62